Too bad we can't rate stocks under $10M Mcap
Why DARA? well its trading for a fraction of what its potential could be, one of its drugs in Phase II has a Potential Market of over $2 Billion.
Now that that the company has already announced a shelf this morning, it removes all risk of downside on such news occuring anymore in the near-term. Plus now it has a recurring revenue stream with the breast cancer drug it did not have prior to yesterday's merger with Oncogenerix and its only FDA approved liquid formulation of tamoxifen for the treatment of breast cancer in the USA. Oncogenerix also working on other generic drugs for blockbuster drugs worth billions in mkt which are coming off Patent protection very soon.
If I could be allowed to pick say only a minimum of 10 of these kind of stocks, I could vastly outperform the market. This type of undervalued stock is what in the real world people find to hit grandslams with.